Collin Kurtenbach

Collin Kurtenbach is a patent litigation attorney at Jones Day, where he focuses on representing clients in asserting and defending their intellectual property rights before U.S. district courts and the International Trade Commission (ITC). His practice leverages a bioengineering background, allowing him to specialize in complex Hatch-Waxman litigation, disputes involving various medical devices, semiconductors, smartphones, and biotechnology. He also handles trade secret matters.

Kurtenbach's experience extends to both sides of patent disputes. While the tracked case shows a defendant-side appearance, his firm profile indicates work as both complainant and defendant. For instance, he was involved in defending Axion BioSystems, Inc. against Agilent Technologies, Inc. in a case involving patent infringement, false advertising, and trade secret misappropriation, which resolved after jury selection. He also represented NXP Semiconductors N.V. as a complainant/plaintiff in a patent infringement dispute against MediaTek Inc. before the ITC and a U.S. District Court.

His expertise in pharmaceutical patent litigation is further demonstrated by his co-authorship of Jones Day commentaries on significant legal developments, including the U.S. Supreme Court's stance on "skinny labels" and induced infringement in Hatch-Waxman cases. While his firm profile does not explicitly detail regular appearances in PTAB or IPR proceedings, his commentary work reflects an engagement with contemporary intellectual property law issues. Prior to his legal career, Kurtenbach gained experience in the research and development and intellectual property departments of Cardinal Health, where he contributed to the design, development, and legal protection of medical devices.

Kurtenbach is admitted to practice in Illinois and was recognized as a "Rising Star" by Illinois Super Lawyers in 2023.